Neutropenia during treatment of rheumatoid arthritis with levamisole
- PMID: 686870
- PMCID: PMC1000246
- DOI: 10.1136/ard.37.4.366
Neutropenia during treatment of rheumatoid arthritis with levamisole
Abstract
Of 60 patients with rheumatoid arthritis treated with levamisole 35% showed a persistent decrease in neutrophil counts from pre-treatment levels and 6 (10%) develped severe neutropenia of less than 1.0 X 10(9)/1. One of these neutropenic patients recoverd without stopping therapy and the other 5 patients recovered rapidly when the drug was withdrawn. In some patients neutropenia recurred on reinstitution of levamisole.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
